vs
加拿大国家铁路（CP）与TENET HEALTHCARE CORP（THC）财务数据对比。点击上方公司名可切换其他公司
TENET HEALTHCARE CORP的季度营收约是加拿大国家铁路的1.9倍（$5.5B vs $2.8B），加拿大国家铁路净利率更高（27.7% vs 11.7%，领先16.0%），TENET HEALTHCARE CORP同比增速更快（9.0% vs 1.3%），加拿大国家铁路自由现金流更多（$537.3M vs $367.0M），过去两年加拿大国家铁路的营收复合增速更高（5.6% vs 1.5%）
加拿大国家铁路是加拿大一级货运铁路企业，总部位于魁北克省蒙特利尔市，业务覆盖加拿大全境及美国中西部、南部区域，是加拿大两大主力货运铁路运营商之一，与加拿大太平洋堪萨斯城铁路公司齐名。
Tenet Healthcare Corporation是总部位于美国达拉斯的营利性跨国医疗服务企业，旗下拥有USPI等多个品牌、子公司、合资企业及合作主体，运营65家医院及超过450个医疗设施，还通过旗下Conifer Health Solutions为各类医疗系统及其他客户提供专业医疗支持服务
CP vs THC — 直观对比
营收规模更大
THC
是对方的1.9倍
$2.8B
营收增速更快
THC
高出7.7%
1.3%
净利率更高
CP
高出16.0%
11.7%
自由现金流更多
CP
多$170.3M
$367.0M
两年增速更快
CP
近两年复合增速
1.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.8B | $5.5B |
| 净利润 | $786.2M | $644.0M |
| 毛利率 | — | — |
| 营业利润率 | 41.4% | 15.4% |
| 净利率 | 27.7% | 11.7% |
| 营收同比 | 1.3% | 9.0% |
| 净利润同比 | -10.3% | 12.6% |
| 每股收益（稀释后） | — | $4.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPTHC
| Q4 25 | $2.8B | $5.5B | ||
| Q3 25 | $2.7B | $5.3B | ||
| Q2 25 | $2.7B | $5.3B | ||
| Q1 25 | $2.8B | $5.2B | ||
| Q4 24 | $2.8B | $5.1B | ||
| Q3 24 | $2.6B | $5.1B | ||
| Q2 24 | $2.6B | $5.1B | ||
| Q1 24 | $2.5B | $5.4B |
净利润CPTHC
| Q4 25 | $786.2M | $644.0M | ||
| Q3 25 | $671.6M | $579.0M | ||
| Q2 25 | $900.8M | $522.0M | ||
| Q1 25 | $664.3M | $622.0M | ||
| Q4 24 | $876.7M | $572.0M | ||
| Q3 24 | $611.0M | $681.0M | ||
| Q2 24 | $660.6M | $477.0M | ||
| Q1 24 | $565.8M | $2.3B |
营业利润率CPTHC
| Q4 25 | 41.4% | 15.4% | ||
| Q3 25 | 36.8% | 16.8% | ||
| Q2 25 | 36.6% | 15.6% | ||
| Q1 25 | 35.0% | 18.1% | ||
| Q4 24 | 40.6% | 16.2% | ||
| Q3 24 | 34.3% | 21.3% | ||
| Q2 24 | 35.4% | 14.9% | ||
| Q1 24 | 32.9% | 61.2% |
净利率CPTHC
| Q4 25 | 27.7% | 11.7% | ||
| Q3 25 | 25.3% | 10.9% | ||
| Q2 25 | 33.6% | 9.9% | ||
| Q1 25 | 24.2% | 11.9% | ||
| Q4 24 | 31.2% | 11.3% | ||
| Q3 24 | 23.9% | 13.3% | ||
| Q2 24 | 25.3% | 9.3% | ||
| Q1 24 | 22.2% | 43.5% |
每股收益（稀释后）CPTHC
| Q4 25 | — | $4.22 | ||
| Q3 25 | — | $3.86 | ||
| Q2 25 | — | $3.14 | ||
| Q1 25 | — | $4.27 | ||
| Q4 24 | — | $3.79 | ||
| Q3 24 | — | $4.89 | ||
| Q2 24 | — | $2.64 | ||
| Q1 24 | — | $21.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $134.3M | $2.9B |
| 总债务越低越好 | $14.6B | $13.1B |
| 股东权益账面价值 | $33.5B | $4.2B |
| 总资产 | $62.7B | $29.7B |
| 负债/权益比越低杠杆越低 | 0.43× | 3.10× |
8季度趋势，按日历期对齐
现金及短期投资CPTHC
| Q4 25 | $134.3M | $2.9B | ||
| Q3 25 | $300.0M | $3.0B | ||
| Q2 25 | $583.3M | $2.6B | ||
| Q1 25 | $507.4M | $3.0B | ||
| Q4 24 | $539.5M | $3.0B | ||
| Q3 24 | $338.0M | $4.1B | ||
| Q2 24 | $406.6M | $2.9B | ||
| Q1 24 | $378.9M | $2.5B |
总债务CPTHC
| Q4 25 | $14.6B | $13.1B | ||
| Q3 25 | $15.8B | $13.1B | ||
| Q2 25 | $15.5B | $13.1B | ||
| Q1 25 | $15.4B | $13.1B | ||
| Q4 24 | $14.5B | $13.1B | ||
| Q3 24 | $13.7B | $12.8B | ||
| Q2 24 | $13.8B | $12.8B | ||
| Q1 24 | $13.7B | $12.8B |
股东权益CPTHC
| Q4 25 | $33.5B | $4.2B | ||
| Q3 25 | $33.4B | $4.0B | ||
| Q2 25 | $33.7B | $3.7B | ||
| Q1 25 | $35.2B | $4.2B | ||
| Q4 24 | $35.0B | $4.2B | ||
| Q3 24 | $32.2B | $3.8B | ||
| Q2 24 | $32.0B | $3.5B | ||
| Q1 24 | $31.3B | $3.5B |
总资产CPTHC
| Q4 25 | $62.7B | $29.7B | ||
| Q3 25 | $63.3B | $29.4B | ||
| Q2 25 | $62.2B | $28.7B | ||
| Q1 25 | $64.3B | $29.2B | ||
| Q4 24 | $64.1B | $28.9B | ||
| Q3 24 | $60.0B | $29.4B | ||
| Q2 24 | $60.4B | $29.3B | ||
| Q1 24 | $59.6B | $28.9B |
负债/权益比CPTHC
| Q4 25 | 0.43× | 3.10× | ||
| Q3 25 | 0.47× | 3.26× | ||
| Q2 25 | 0.46× | 3.49× | ||
| Q1 25 | 0.44× | 3.13× | ||
| Q4 24 | 0.41× | 3.14× | ||
| Q3 24 | 0.42× | 3.33× | ||
| Q2 24 | 0.43× | 3.67× | ||
| Q1 24 | 0.44× | 3.70× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.1B | $731.0M |
| 自由现金流经营现金流 - 资本支出 | $537.3M | $367.0M |
| 自由现金流率自由现金流/营收 | 18.9% | 6.6% |
| 资本支出强度资本支出/营收 | 20.2% | 6.6% |
| 现金转化率经营现金流/净利润 | 1.42× | 1.14× |
| 过去12个月自由现金流最近4个季度 | $1.6B | $2.5B |
8季度趋势，按日历期对齐
经营现金流CPTHC
| Q4 25 | $1.1B | $731.0M | ||
| Q3 25 | $930.0M | $1.1B | ||
| Q2 25 | $989.1M | $936.0M | ||
| Q1 25 | $843.9M | $815.0M | ||
| Q4 24 | $1.2B | $-331.0M | ||
| Q3 24 | $928.6M | $1.0B | ||
| Q2 24 | $932.9M | $747.0M | ||
| Q1 24 | $741.0M | $586.0M |
自由现金流CPTHC
| Q4 25 | $537.3M | $367.0M | ||
| Q3 25 | $302.2M | $778.0M | ||
| Q2 25 | $446.8M | $743.0M | ||
| Q1 25 | $324.9M | $642.0M | ||
| Q4 24 | $702.3M | $-661.0M | ||
| Q3 24 | $382.5M | $829.0M | ||
| Q2 24 | $343.1M | $602.0M | ||
| Q1 24 | $356.2M | $346.0M |
自由现金流率CPTHC
| Q4 25 | 18.9% | 6.6% | ||
| Q3 25 | 11.4% | 14.7% | ||
| Q2 25 | 16.7% | 14.1% | ||
| Q1 25 | 11.8% | 12.3% | ||
| Q4 24 | 25.0% | -13.0% | ||
| Q3 24 | 15.0% | 16.2% | ||
| Q2 24 | 13.1% | 11.8% | ||
| Q1 24 | 14.0% | 6.4% |
资本支出强度CPTHC
| Q4 25 | 20.2% | 6.6% | ||
| Q3 25 | 23.7% | 5.3% | ||
| Q2 25 | 20.2% | 3.7% | ||
| Q1 25 | 18.9% | 3.3% | ||
| Q4 24 | 19.3% | 6.5% | ||
| Q3 24 | 21.4% | 4.2% | ||
| Q2 24 | 22.6% | 2.8% | ||
| Q1 24 | 15.1% | 4.5% |
现金转化率CPTHC
| Q4 25 | 1.42× | 1.14× | ||
| Q3 25 | 1.38× | 1.83× | ||
| Q2 25 | 1.10× | 1.79× | ||
| Q1 25 | 1.27× | 1.31× | ||
| Q4 24 | 1.42× | -0.58× | ||
| Q3 24 | 1.52× | 1.53× | ||
| Q2 24 | 1.41× | 1.57× | ||
| Q1 24 | 1.31× | 0.25× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CP
暂无分部数据
THC
| Other | $2.9B | 52% |
| Health Care Patient Service | $1.4B | 25% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $1.2B | 22% |
| Health Care Other Sources | $56.0M | 1% |
